Glycemic load effect on fasting and post-prandial serum glucose, insulin, IGF-1 and IGFBP-3 in a randomized, controlled feeding study

European Journal of Clinical Nutrition

Volumn 66, Issue 10, 2012, Pages 1146-1152

  Runchey, S S ^a,b   Pollak, M N ^c   Valsta, L M ^d   Coronado, G D ^e   Schwarz, Y ^b   Breymeyer, K L ^b   Wang, C ^b   Wang, C Y ^b   Lampe, J W ^a,b   Neuhouser, M L ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d EUROPEAN FOOD SAFETY AUTHORITY   (Italy)

^e CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

adiposity; glycemic index; insulin resistance; insulin like growth factor 1; insulin like growth factor binding protein 3; randomized controlled trial

Indexed keywords

GLUCOSE; INSULIN; RINFABATE; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; FEEDING; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC LOAD; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN RESPONSE; MAJOR CLINICAL STUDY; MALE; MEAL; OBESITY; POSTPRANDIAL STATE; RISK FACTOR; STUDENT T TEST;

ADULT; ALGORITHMS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CROSS-OVER STUDIES; DIETARY CARBOHYDRATES; FEMALE; GLYCEMIC INDEX; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; OBESITY; OVERWEIGHT; YOUNG ADULT;

EID: 84867103691     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2012.107     Document Type: Article

References (48)

1. Opperman AM, Venter CS, Oosthuizen W, Thompson RL, Vorster HH. Meta-analysis of the health effects of using the glycaemic index in meal-planning. Br J Nutr 2004; 92: 367-381.
2. Pawlak DB, Ebbeling CB, Ludwig DS. Should obese patients be counselled to follow a low-glycaemic index diet? Yes. Obes Rev 2002; 3: 235-243.
3. Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM et al. Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 1981; 34: 362-366.
4. Jenkins DJ, Kendall CW, Augustin LS, Franceschi S, Hamidi M, Marchie A et al. Glycemic index: overview of implications in health and disease. Am J Clin Nutr 2002; 76: 266S-273S.
5. Salmeron J, Ascherio A, Rimm EB, Colditz GA, Spiegelman D, Jenkins DJ et al. Dietary fiber, glycemic load, and risk of NIDDM in men. Diabetes Care 1997; 20: 545-550.
6. Salmeron J, Manson JE, Stampfer MJ, Colditz GA, Wing AL, Willett WC. Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA 1997; 277: 472-477.
7. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345: 790-797.
8. Gnagnarella P, Gandini S, La Vecchia C, Maisonneuve P. Glycemic index, glycemic load, and cancer risk: a meta-analysis. Am J Clin Nutr 2008; 87: 1793-1801.
9. Mulholland HG, Murray LJ, Cardwell CR, Cantwell MM. Glycemic index, glycemic load, and risk of digestive tract neoplasms: a systematic review and meta-analysis. Am J Clin Nutr 2009; 89: 568-576.
10. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004; 4: 505-518.
11. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. The ratio between serum levels of insulin-like growth factor (IGFBP-1, 2 and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol 1994; 41: 85-93.
12. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346-1353.
13. Sierra-Johnson J, Romero-Corral A, Somers VK, Lopez-Jimenez F, Malarstig A, Brismar K et al. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clin Sci 2009; 116: 507-512.
14. Lam CS, Chen MH, Lacey SM, Yang Q, Sullivan LM, Xanthakis V et al. Circulating insulin-like growth factor-1 and its binding protein-3: metabolic and genetic correlates in the community. Arterioscler Thromb Vasc Biol 2010; 30: 1479-1484.
15. Clemmons DR. Role of insulin-like growth factor iin maintaining normal glucose homeostasis. Horm Res 2004; 62 (Suppl 1): 77-82.
16. Holmes MD, Pollak MN, Willett WC, Hankinson SE. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations. Cancer Epidemiol Biomarkers Prev 2002; 11: 852-861.
17. Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS et al. The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 1998; 83: 1467-1471.
18. Brand-Miller JC, Liu V, Petocz P, Baxter RC. The glycemic index of foods influences postprandial insulin-like growth factor-binding protein responses in lean young subjects. Am J Clin Nutr 2005; 82: 350-354.
19. Smith R, Mann N, Makelainen H, Roper J, Braue A, Varigos G. A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial. Mol Nutr Food Res 2008; 52: 718-726.
20. Smith RN, Mann NJ, Braue A, Makelainen H, Varigos GA. The effect of a highprotein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator- masked, controlled trial. J Am Acad Dermatol 2007; 57: 247-256.
21. Coronado GD, Ondelacy S, Schwarz Y, Duggan C, Lampe JW, Neuhouser ML. Recruiting underrepresented groups into the carbohydrates and related biomarkers CARB) cancer prevention feeding study. Contemp Clin Trials 2012; 33: 641-646.
22. Neuhouser ML, Schwarz Y, Wang C, Breymeyer K, Coronado G, Wang CY et al. A low-glycemic load diet reduces serum C-reactive protein and modestly increases adiponectin in overweight and obese adults. J Nutr 2012; 142: 369-374.
23. Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr 1990; 51: 241-247.
24. Brand-Miller JC, Thomas M, Swan V, Ahmad ZI, Petocz P, Colagiuri S. Physiological validation of the concept of glycemic load in lean young adults. J Nutr 2003; 133: 2728-2732.
25. Foster-Powell K, Holt SH, Brand-Miller JC. International table of glycemic index and glycemic load values 2002Am J Clin Nutr 2002; 76: 5-56.
26. Wolever TM, Jenkins DJ. The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr 1986; 43: 167-172.
27. Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ et al. Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels. Diabetes Care 2009; 32: 335-341.
28. Rudenski AS, Matthews DR, Levy JC, Turner RC. Understanding 'insulin resistance': both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 1991; 40: 908-917.
29. Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL et al. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr 2009; 89: 500-508.
30. Samani AA, Yakar S, LeRoith D, Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 2007; 28: 20-47.
31. Giovannucci E. Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr 2001; 131: 3109S-3120S.
32. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB et al. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 2003; 12: 84-89.
33. Isley WL, Underwood LE, Clemmons DR. Dietary components that regulate serum somatomedin-C concentrations in humans. J Clin Invest 1983; 71: 175-182.
34. Thissen JP, Ketelslegers JM, Underwood LE. Nutritional regulation of the insulinlike growth factors. Endocr Rev 1994; 15: 80-101.
35. McGreevy KM, Hoel BD, Lipsitz SR, Hoel DG. Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutr 2007; 10: 97-105.
36. Gann PH, Kazer R, Chatterton R, Gapstur S, Thedford K, Helenowski I et al. Sequential, randomized trial of a low-fat, high-fiber diet and soy supplementation: effects on circulating IGF-I and its binding proteins in premenopausal women. Int J Cancer 2005; 116: 297-303.
37. Flood A, Mai V, Pfeiffer R, Kahle L, Remaley AT, Rosen CJ et al. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3. Eur J Clin Nutr 2008; 62: 186-196.
38. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002; 359: 1740-1745.
39. Brugts MP, van Duijn CM, Hofland LJ, Witteman JC. Lamberts SW, Janssen JA. Igf-I bioactivity in an elderly population: relation to insulin sensitivity, insulin levels, and the metabolic syndrome. Diabetes 2010; 59: 505-508.
40. Livesey G, Taylor R, Hulshof T, Howlett J. Glycemic response and health-a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes. Am J Clin Nutr 2008; 87: 258S-268S.
41. Vrolix R, Mensink RP. Effects of glycemic load on metabolic risk markers in subjects at increased risk of developing metabolic syndrome. Am J Clin Nutr 2010; 92: 366-374.
42. Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein. Am J Clin Nutr 2008; 87: 114-125.
43. Lan-Pidhainy X, Wolever TM. Are the glycemic and insulinemic index values of carbohydrate foods similar in healthy control, hyperinsulinemic and type 2 diabetic patients? Eur J Clin Nutr 2011; 65: 727-734.
44. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low-glycemic index diets in the management of diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2003; 26: 2261-2267.
45. Andersson U, Rosen L, Wierup N, Ostman E, Bjorck I, Holm C. A low glycaemic diet improves oral glucose tolerance but has no effect on beta-cell function in C57BL/6J mice. Diabetes Obes Metab 2010; 12: 976-982.
46. Solomon TP, Haus JM, Kelly KR, Cook MD, Filion J, Rocco M et al. A low-glycemic index diet combined with exercise reduces insulin resistance, postprandial hyperinsulinemia, and glucose-dependent insulinotropic polypeptide responses in obese, prediabetic humans. Am J Clin Nutr 2010; 92: 1359-1368.
47. Frystyk J, Grofte T, Skjaerbaek C, Orskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J Clin Endocrinol Metab 1997; 82: 3124-3127.
48. Murphy LJ. The role of the insulin-like growth factors and their binding proteins in glucose homeostasis. Exp Diabesity Res 2003; 4: 213-224.